Duncan, Laramie http://orcid.org/0000-0003-1131-661X
Deisseroth, Karl
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH123486, MH125358)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Article History
Received: 31 March 2023
Revised: 11 May 2023
Accepted: 19 May 2023
First Online: 8 July 2023
Competing interests
: LD has no competing interests. KD is a cofounder and consultant for Maplight Therapeutics.